# Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effectiveness-and-safety-of-adalimumab-biosimilar-in-inflammatory-bowel-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nagesh Kamat,Saurabh Kedia,Uday C. Ghoshal,Abhimanyu Nehra,Govind Makharia,Ajit Sood,Vandana Midha,Varun Gupta,Gourdas Choudhuri,Vineet Ahuja |
| Citations | 35 |
| DOI | 10.1007/s12664-018-0922-1 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2909473777 |
| PMID | 30645725 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Nagesh Kamat](https://scholariq.org/researchers/nagesh-kamat/)

## Paper journal

- [Indian Journal of Gastroenterology](https://scholariq.org/journals/indian-journal-of-gastroenterology/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.